N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3Integrin Antagonists
Citations Over TimeTop 10% of 1999 papers
Abstract
The alpha(V)beta(3) integrin receptor plays an important role in human tumor metastasis and tumor-induced angiogenesis. The in vivo inhibition of this receptor by antibodies or by cyclic peptides containing the RGD sequence may in the future be used to selectively suppress these diseases. Here we investigate the influence of N-methylation of the active and selective alpha(V)beta(3) antagonist cyclo(RGDfV) (L1) on biological activity. Cyclo(RGDf-N(Me)V-) (P5) was found to be even more active than L1 and is one of the most active and selective compounds in inhibiting vitronectin binding to the alpha(V)beta(3) integrin. Its high-resolution, three-dimensional structure in water was determined by NMR techniques, distance geometry calculations, and molecular dynamics calculations, providing more insight into the structure-activity relationship.
Related Papers
- → Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen(1992)234 cited
- → Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells(2014)23 cited
- → Expression of αv, α4, α5 and β3 integrin subunits, fibronectin and vitronectin in goat peri-implantation(2003)27 cited
- → Ligation of Integrin α5β1 Is Required for Internalization of Vitronectin by Integrin αvβ3(1997)66 cited
- → Vitronectin-Binding Integrins in Cancer(2009)3 cited